A-Alpha Bio
A Senior Account Executive at A-Alpha Bio will own the end‑to‑end sales process for the Western North America and APAC territories, driving revenue across the full product portfolio of data subscriptions, licenses, and antibody optimization programs. The role involves hunting new logos, expanding existing accounts, and managing complex, multi‑stakeholder sales cycles with scientific buyers in pharma, biotech, and AI‑driven drug discovery.
Headquarters
Seattle, Washington, United States
Company Size
51-200 employees
Founded
2017
A-Alpha Bio is a biotechnology company that harnesses synthetic biology and machine learning to engineer high-impact medicines by measuring, predicting, and engineering protein-protein interactions at scale. Their proprietary AlphaSeq platform enables quantitative, multiplexed characterization of millions of protein interactions simultaneously, building the world's largest repository of high-quality protein interaction data. This data powers their AlphaBind machine learning models to accelerate the discovery and optimization of antibodies, degraders, and other protein-based therapeutics.
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth
Sep 23, 2025
Occam Global Recruits Chief Business Officer for A-Alpha Bio
Oct 31, 2025
Tech Moves: Yoodli, A-Alpha Bio, MoxiWorks add execs, TiE Seattle names president
Sep 25, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for A-Alpha Bio.
Seattle top biotechs 2025: the 9 companies you should now about
Nov 11, 2025